|
|
|
NBSA News & Information on Upcoming Events |
|
BioSafety News |
|
Upcoming Events: Joint meeting with SESHA |
|
Previous Events: Biotechnology
in BD, Risk Assessment in Nanotechnology Swaitoslav Kaczmar,
O’Brien & Gere OSHA’s
Plans for Regulating Occupational Exposure to Infectious Agents David Hill, Testing and
Performance Verification Methodologies for BSL-3 Labs Louis DiBerardinis,
Massachusetts Institute of Technology (MIT) Howard Cohen, Department of Occupational
and Environmental Medicine, 2010 A High Level Overview of
Biosecurity Policy-William Banks, J.D., M.S., Director, Institute for
National Security and Counterterrorism (INSCT), Strengthening Laboratory Biosecurity - Working Group Report- Eric Jeppson, Midwest Research Institute Synthetic Biology and Proposed Revisions to the NIH Guidelines-Jaqueline Corrigan-Curray, J.D., M.D., NIH Office of Biotechnology Activities. Laboratory
Biosafety Competency Development for the BSL 2,3, and 4- Michael
Pantella, PhD (ABMM) Biosafety Considerations for Human
SCID Mouse and Stem Cell Programs-Gerold Feurr, Ph.D., Biosafety
Considerations for Gene Therapy Viral Vectors-Dawn Post,
Ph.D., Medical Support Services - Considerations for High-Risk Pathogens-Sarah Elmendorf, M.D., Upstate Infectious Disease Associates Biohazards in Forensics-
Mike Marciano, M.S., 2009 Joint Symposium with IStAATT Welcome to Welcome from NBSA President Paul Tranchell Welcome..IStAATT Ira Salkin MWTA/STAATT The Beginning- Ira Salkin Issues and Applications of Biological Indicators- Craig Wallace Treatment Technologies Then and Now- Ed Krisiunas Efficacy Testing..Laboratory Issues- Paul Warden Biosafety Considerations in Waste Management- Frank Cantone Biosafety Considerations in Waste Management- J. Paul Jenette Autoclaves..History and Applications- Alan Woodard Autoclaves..Validation Testing- Corey Bennett Effluent decontamination systems- Shanon Jones Caustic Digester Units -Gordon Kaye Safer Together: Building a Multidisciplinary Biological Safety Network Caryl Griffin, President, Elizabeth R. Griffin Research Foundation High Pathogen Avian Influenza and Risk Management Dr. Deborah Fuller, Plague Endotoxin and Evasion of Innate Immunity Dr. Egil Lien, Associate Professor of Medicine, University of
The NIH rDNA Guidelines: Emerging Issues and Common Dr. Kathryn Harris, Office of Biotechnology Activities, NIH Implementing the Science Training Program at Lovelace Respiratory Research Institute, Penny Holeman, Director of EH&S and Biological Safety, Lovelace Respiratory Research Institute BSL-3-Ag: Research in High Containment Animal Laboratories Luis L. Rodriguez D.V.M., Ph.D., Research Leader, Foreign
Animal Disease Research Unit, USDA/ARS 2007 Symposium Topics included 2006 Symposium Click on the following links for PDF fliers Laboratory Diagnosis of BSE and CWD: Procedures and Precautions, Dr.
Alfonso Torres, Executive Dir., Biosafety in the Mycology Laboratory, Dr. Ira Salkin, Information From Science, LLC Case Study:Biosafety Response during an Outbreak of LCM in the Animal Facility, Ms. Tina Charbonneau, BSO, Trudeau Institute Current Issues for IBCs: The Importance of Promoting Biosafety in Today's Research Climate, Mr. Allan Shipp, Office of Biotechnology Activities, NIH New Frontiers In Influenza Research, Dr. David Woodland, Trudeau Institute Pandemic Influenza Planning and Preparedness, Dr. Barbara Wallace, Dir. Bureau of Communicable Disease Control, NYS Dept. of Health
NORTHEAST BIOLOGICAL SAFETY ASSOCIATION Opening Remarks State and Local Emergency Response to
Biohazardous Indcidents Biosafety Consideration for Viral
Vectors Select Agents and Associated
Biosafety/Biosecurity Considerations Round Table Discussion Announcements and Open Forum |